Putting the STING Back into BH3-Mimetic Drugs for TP53-Mutant Blood Cancers

Investigators reported that p53 was activated following BH3-mimetic induced mitochondrial outer membrane permeabilization, leading to BH3-only protein induction and thereby potentiating the pro-apoptotic signal.